This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stiles, B. G. Articles by Bonventre, P. F. Search for Related Content PubMed PubMed Citation Articles by Stiles, B. G. Articles by Bonventre, P. F.

 Previous Article  |  Next Article 

Infect. Immun., Apr 1995, 1229-1234, Vol 63, No. 4
Copyright © 1995, American Society for Microbiology

Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model

BG Stiles, T Krakauer and PF Bonventre
Division of Toxinology, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702-5011.

A recombinant of toxic shock syndrome toxin 1 (TSST-1) which contains a single histidine-to-alanine mutation at residue 135 (H135A) was analyzed for toxicity and vaccine potential in a lipopolysaccharide (LPS)-potentiated mouse lethality model. The 50% lethal dose (LD50) of TSST-1 in BALB/c mice was 47.2 micrograms/kg, but H135A was not lethal when tested at a dose equivalent to 10 LD50s of TSST-1. Levels of tumor necrosis factor (TNF) and gamma interferon (IFN-gamma) in serum were, respectively, 10- and 50-fold higher in LPS-potentiated mice injected with 15 LD50s of TSST-1 than in mice given H135A. Mice injected with only TSST-1 did not have elevated levels of TNF or IFN-gamma in serum, while H135A plus LPS or LPS alone elicited identical, yet very low, levels of TNF and IFN-gamma. An enzyme-linked immunosorbent assay of H135A and TSST-1 with anti-TSST-1 serum yielded very similar dose- response curves, which strongly suggests that H135A serologically and conformationally resembles the native toxin. Mice immunized with H135A developed antibodies that recognized TSST-1 in an enzyme-linked immunosorbent assay and afforded protection against a 15-LD50 challenge of TSST-1 plus LPS. The pooled sera of mice immunized with either TSST- 1 or H135A also prevented lymphocyte proliferation due to TSST-1.

This article has been cited by other articles:

• Hale, M. L., Margolin, S. B., Krakauer, T., Roy, C. J., Stiles, B. G. (2002). Pirfenidone Blocks the In Vitro and In Vivo Effects of Staphylococcal Enterotoxin B. Infect. Immun. 70: 2989-2994 [Abstract] [Full Text]  
• Kum, W. W. S., Cameron, S. B., Hung, R. W. Y., Kalyan, S., Chow, A. W. (2001). Temporal Sequence and Kinetics of Proinflammatory and Anti-Inflammatory Cytokine Secretion Induced by Toxic Shock Syndrome Toxin 1 in Human Peripheral Blood Mononuclear Cells. Infect. Immun. 69: 7544-7549 [Abstract] [Full Text]  
• Stiles, B. G., Garza, A. R., Ulrich, R. G., Boles, J. W. (2001). Mucosal Vaccination with Recombinantly Attenuated Staphylococcal Enterotoxin B and Protection in a Murine Model. Infect. Immun. 69: 2031-2036 [Abstract] [Full Text]  
• Dinges, M. M., Schlievert, P. M. (2001). Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice. Infect. Immun. 69: 1256-1264 [Abstract] [Full Text]  
• Krakauer, T., Stiles, B. G. (1999). Pentoxifylline Inhibits Superantigen-Induced Toxic Shock and Cytokine Release. CVI 6: 594-598 [Abstract] [Full Text]  
• Stiles, B. G., Campbell, Y. G., Castle, R. M., Grove, S. A. (1999). Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1. Infect. Immun. 67: 1521-1525 [Abstract] [Full Text]